Peter Farnum Wright

Q: What Schools Are Affiliated With Peter Farnum Wright

Peter Farnum Wright is affiliated with the following schools: George Washington University, Université de Montréal, Dartmouth College, Vanderbilt University

Peter Farnum Wright's AcademicInfluence.com Rankings

Peter Farnum Wright

Medical

#2201

World Rank

#2607

Historical Rank

Public Health

#324

World Rank

#336

Historical Rank

Epidemiology

#373

World Rank

#392

Historical Rank

medical Degrees

Download Badge

Medical

Peter Farnum Wright's Degrees

PhD Epidemiology University of California, Berkeley
Masters Public Health University of California, Berkeley
Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Peter Farnum Wright Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Farnum Wright's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis (2010) (2325)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. (2005) (1780)
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. (2000) (1118)
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis (2011) (815)
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. (2004) (771)
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. (2000) (668)
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. (1991) (518)
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. (1991) (422)
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. (2002) (421)
The histopathology of fatal untreated human respiratory syncytial virus infection (2007) (418)
The burden of influenza illness in children with asthma and other chronic medical conditions. (2000) (406)
Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1 (2004) (392)
Primary respiratory syncytial virus infection in mice (1988) (369)
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. (1994) (362)
Antiretroviral therapy in a thousand patients with AIDS in Haiti. (2005) (317)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. (2000) (315)
Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis. (1993) (296)
Changing presentation of herpes simplex virus infection in neonates. (1988) (290)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. (2005) (271)
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience (2001) (259)
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. (2006) (232)
Circulating vaccine-derived polioviruses: current state of knowledge. (2004) (219)
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. (1971) (214)
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. (1997) (209)
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. (1997) (203)
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. (1998) (201)
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. (1986) (199)
Simultaneous Detection and High-Throughput Identification of a Panel of RNA Viruses Causing Respiratory Tract Infections (2007) (171)
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. (1994) (167)
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection (1986) (166)
Measurement of Human Cytomegalovirus Loads by Quantitative Real-Time PCR for Monitoring Clinical Intervention in Transplant Recipients (2003) (165)
An outbreak of airborne nosocomial varicella. (1982) (160)
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. (2001) (153)
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines (1982) (153)
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. (1983) (153)
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors (2016) (150)
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults (1993) (149)
Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. (1977) (147)
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. (2002) (146)
A fatal central nervous system enterovirus 68 infection. (2011) (145)
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. (2007) (143)
Canine kidney cell line for isolation of respiratory viruses (1979) (142)
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study (2013) (137)
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. (1992) (133)
Primary vaccine failure after 1 dose of varicella vaccine in healthy children. (2008) (132)
Adenovirus infections in young children. (1985) (125)
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. (1995) (125)
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children (1982) (125)
Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. (2004) (122)
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. (1999) (122)
Aprotinin and similar protease inhibitors as drugs against influenza. (2011) (120)
Prolonged evolution of the human B cell response to SARS-CoV-2 infection (2021) (119)
Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies (2010) (115)
Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. (2002) (114)
Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood (1987) (112)
Prevalence of Reovirus-Specific Antibodies in Young Children in Nashville, Tennessee (2005) (112)
Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized With Recombinant gp 120 From the MN Strain of HIV-1 (1994) (111)
Differing virulence of H1N1 and H3N2 influenza strains. (1980) (109)
Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. (1973) (108)
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. (1988) (105)
Candidate AIDS vaccines. (1995) (104)
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. (2009) (104)
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. (1995) (102)
Frequency of broviac catheter infections in pediatric oncology patients. (1986) (102)
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. (1982) (100)
Strategies for the global eradication of poliomyelitis by the year 2000. (1991) (100)
Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades (2012) (99)
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. (2006) (99)
Haemophilus influenzae : epidemiology, immunology, and prevention of disease (1982) (98)
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation (2018) (97)
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. (1977) (96)
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. (1976) (96)
Cleavage of Influenza A Virus Hemagglutinin in Human Respiratory Epithelium Is Cell Associated and Sensitive to Exogenous Antiproteases (2002) (93)
Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. (1983) (93)
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. (1994) (93)
Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. (1977) (91)
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. (1998) (89)
Comparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine (1985) (89)
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. (1996) (87)
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory (1983) (87)
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. (2008) (85)
Antiretroviral therapy for HIV-1-infected children in Haiti. (2007) (85)
Growth of Respiratory Syncytial Virus in Primary Epithelial Cells from the Human Respiratory Tract (2005) (85)
Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. (2000) (85)
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. (2000) (84)
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge. (2016) (83)
Comparison of Results of Detection of Rhinovirus by PCR and Viral Culture in Human Nasal Wash Specimens from Subjects with and without Clinical Symptoms of Respiratory Illness (2007) (83)
A comparison of five serological tests for bovine brucellosis. (1986) (83)
Temperature-sensitive Mutants of Respiratory Syncytial Virus (1969) (83)
Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection (1993) (82)
The Feasibility, Demand, and Effect of Integrating Primary Care Services with HIV Voluntary Counseling and Testing: Evaluation of a 15‐Year Experience in Haiti, 1985‐2000 (2003) (81)
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. (1996) (78)
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants (2003) (77)
The Pediatric Burden of Human Coronaviruses Evaluated for Twenty Years (2009) (77)
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. (1997) (77)
Immune correlates of protection against influenza in the human challenge model. (2003) (76)
From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. (1976) (76)
Impact of recurrent otitis media on middle ear function, hearing, and language. (1988) (75)
Eustachian Tube Histopathology during Experimental Influenza a Virus Infection in the Chinchilla (1987) (73)
Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59 (1996) (73)
Pneumococcal vaccine in normal children. Primary and secondary vaccination. (1983) (72)
Medical and Economic Impact of a Respiratory Syncytial Virus Outbreak in a Neonatal Intensive Care Unit (2005) (72)
Epidemiology of HIV Infection and Risk in Adolescents and Youth (2010) (72)
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. (1981) (72)
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. (2008) (71)
Respiratory syncytial virus infection in anti-mu-treated mice (1991) (71)
Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. (1999) (71)
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. (2004) (71)
Detection of mucosal antibodies in HIV type 1-infected individuals. (2002) (70)
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120. (2001) (69)
Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs (2013) (69)
B Cell Response and Hemagglutinin Stalk-Reactive Antibody Production in Different Age Cohorts following 2009 H1N1 Influenza Virus Vaccination (2013) (68)
Clinical implications of preseptal (periorbital) cellulitis in childhood. (1978) (68)
Cholera Vaccination in Urban Haiti (2013) (67)
Vaccine preparedness--are we ready for the next influenza pandemic? (2008) (64)
Evaluation of a new highly purified pertussis vaccine in infants and children. (1989) (64)
Reinfection of mice with respiratory syncytial virus (1991) (63)
Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components. (1986) (60)
The Human Polymeric Immunoglobulin Receptor Facilitates Invasion of Epithelial Cells by Streptococcus pneumoniae in a Strain-Specific and Cell Type-Specific Manner (2002) (58)
Influenza A virus-associated acute necrotizing encephalopathy in the United States. (2004) (57)
Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. (2003) (57)
An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children (2011) (56)
Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas (1983) (56)
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. (2004) (56)
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals (2021) (55)
A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children (1987) (55)
Patterns of illness in the highly febrile young child: epidemiologic, clinical, and laboratory correlates. (1981) (55)
Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium (2012) (55)
A real‐time PCR assay to identify and discriminate among wild‐type and vaccine strains of varicella‐zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses (2009) (54)
Competitive ELISA for Serodiagnosis of Bluetongue: Evaluation of Group-Specific Monoclonal Antibodies and Expressed VP7 Antigen (1992) (53)
Challenges to Conducting HIV Preventative Vaccine Trials With Adolescents (2004) (52)
Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. (1971) (52)
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. (1980) (51)
Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells following Smallpox Immunization1 (2005) (51)
Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. (1994) (51)
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. (1970) (50)
Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center. (1996) (50)
Complications of occult pneumococcal bacteremia in children. (1974) (50)
Live attenuated and inactivated influenza vaccines in children. (2015) (49)
Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. (1976) (49)
Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. (1997) (49)
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. (2004) (49)
Signaling through the Prostaglandin I2 Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness (2004) (48)
The Use of an Educational Video During Informed Consent in an HIV Clinical Trial in Haiti (2006) (46)
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants (2016) (46)
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women. (2010) (46)
Otitis media in infancy: tympanometric findings. (1979) (44)
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. (1999) (44)
Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children. (1991) (44)
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. (2009) (43)
Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. (1976) (43)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers. (2013) (43)
The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. (1981) (43)
When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. (2009) (42)
Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. (1981) (42)
Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes. (1985) (42)
The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. (2011) (42)
Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. (1993) (42)
Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. (1987) (41)
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. (2008) (41)
Common genetic susceptibility loci link PFAPA syndrome, Behçet’s disease, and recurrent aphthous stomatitis (2020) (41)
Application of a timing protocol to the reduction of inter-plate variability in the indirect enzyme immunoassay for detection of anti-Brucella antibody. (1985) (40)
The natural history of human immunodeficiency virus 1 infection in Haitian infants. (1999) (39)
Current status of vaccines for parainfluenza virus infections. (2008) (39)
Ability of human cord blood lymphocytes to mediate antibody-dependent cellular cytotoxicity against influenza virus-infected cells (1983) (39)
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection (1986) (39)
Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. (2014) (39)
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. (2008) (38)
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. (1994) (37)
Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. (1985) (37)
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and B. (1999) (36)
Development of a more thermostable poliovirus vaccine. (1997) (35)
Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120 (2007) (35)
Chronic recurrent multifocal osteomyelitis: are mycoplasmas involved? (1987) (35)
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. (1993) (34)
Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince (2009) (34)
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine (2016) (34)
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children (1985) (34)
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). (1975) (34)
Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up. (2016) (33)
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus (1980) (33)
Comparative performance of the enzyme-linked immunosorbent assay (ELISA) and conventional assays in the diagnosis of bovine brucellosis in Argentina. (1995) (32)
Ureaplasma urealyticum polyarthritis in agammaglobulinemia. (1985) (32)
Histoplasmosis During Childhood (1994) (30)
Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids (1996) (30)
Nursery Epidemic Due to Multiply-Resistant Klebsiella pneumoniae: Epidemiologic Setting and Impact on Perinatal Health Care Delivery (1982) (30)
Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. (2008) (29)
Clinical-histopathological correlations in experimental otitis media: implications for silent otitis media in humans. (1985) (29)
Detection of Viruses in Human Adenoid Tissues by Use of Multiplex PCR (2009) (29)
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. (2006) (29)
Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. (1979) (29)
Prevention of mother-to-child transmission of HIV in Haiti. (2009) (28)
Surveillance of Childhood Influenza Virus Infection: What Is the Best Diagnostic Method To Use for Archival Samples? (2004) (28)
Global immunization--a medical perspective. (1995) (28)
Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval. (1995) (27)
Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting (2008) (27)
Role of complement in neutralization of respiratory syncytial virus (2004) (27)
Infectious diseases in early life in industrialized countries. (1998) (26)
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine (2018) (26)
Antibody Responses After Inactivated Influenza Vaccine in Young Children (2008) (26)
Infectious diseases in early life in industrialized countries. (1998) (26)
Treatment of atypical mycobacterial cervical adenitis with rifampin. (1975) (26)
Blocking dot-ELISA, using a monoclonal antibody for detection of antibodies to bluetongue virus in bovine and ovine sera. (1987) (26)
Differences in serum cytokine levels between influenza virus A and B infections in children. (2009) (26)
Management of genital herpes simplex virus infection occurring during pregnancy. (1981) (25)
Hyperimmunoglobulinemia E syndrome: association with osteoporosis and recurrent fractures. (1985) (25)
Progress in worldwide control and elimination of disease through immunization. (1989) (25)
Distribution of lymphoid leukosis virus and p27 group-specific antigen in tissues from laying hens. (1984) (25)
Failure of intraventricular gamma globulin to eradicate echovirus encephalitis in a patient with X-linked agammaglobulinemia. (1985) (24)
Age-related response to two Haemophilus influenzae type b vaccines. (1982) (24)
Role of Respiratory Tract Proteases in Infectivity of Influenza A Virus (1987) (24)
Tetravalent rhesus rotavirus vaccine in young infants. (1994) (24)
Predictors of Disease Severity in Patients Admitted to a Cholera Treatment Center in Urban Haiti (2013) (23)
Viral infections of the respiratory tract (1999) (23)
Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines. (1993) (23)
Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. (1987) (23)
Generalized viral illness caused by an intermediate strain of adenovirus (21/H21 + 35). (1980) (23)
Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. (1991) (22)
Adapting and Implementing a Community Program to Improve Retention in Care among Patients with HIV in Southern Haiti: “Group of 6” (2014) (22)
Comparison of live and inactivated influenza vaccine in high risk children. (1987) (22)
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial (2018) (22)
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children (2018) (22)
Imaging of pediatric mediastinal histoplasmosis. (1991) (22)
Do childhood vaccines have non-specific effects on mortality? (2003) (22)
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. (1996) (21)
Approaches to prevent acute bacterial meningitis in developing countries. (1989) (21)
Potential of a Simplified p24 Assay for Early Diagnosis of Infant Human Immunodeficiency Virus Type 1 Infection in Haiti (2007) (20)
Correlation of Nasopharyngeal and Conjunctival Cultures with Middle Ear Fluid Cultures in Otitis Media (1986) (20)
HIV‐1 recombinant gp160 vaccine given in accelerated dose schedules (1994) (20)
HIV infection in vaccinated volunteers. (1994) (19)
Dot-enzyme immunoassay for visual detection of antibodies to pseudorabies virus in swine serum (1986) (19)
Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination. (1999) (19)
Importance of cholera and other etiologies of acute diarrhea in post-earthquake Port-au-Prince, Haiti. (2014) (19)
Viruses and Cells with Mutations Affecting Viral Entry Are Selected during Persistent Rotavirus Infections of MA104 Cells (1998) (19)
Serologic imprint of dengue virus in urban Haiti: characterization of humoral immunity to dengue in infants and young children. (2011) (18)
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. (2000) (18)
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh (2018) (18)
Selective Impact of HIV Disease Progression on the Innate Immune System in the Human Female Reproductive Tract (2012) (18)
Antibody decline in children following A/New Jersey/76 influenza virus immunization. (1980) (18)
Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B (2016) (18)
Pertussis in developing countries: definition of the problem and prospects for control. (1991) (18)
Contribution of Bacterial Sepsis to Morbidity in Infants Born to HIV-Infected Haitian Mothers (2006) (18)
Evaluation of a reassortant rhesus rotavirus vaccine in young children. (1990) (18)
Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccines. (1977) (17)
Evaluation of Fever in Infants Less Than 8 Weeks Old (1987) (17)
Human adenoid organ culture: a model to study the interaction of influenza A with human nasopharyngeal mucosa. (1986) (17)
A longitudinal study of the detection of otitis media in the first two years of life. (1985) (17)
Consideration of Postpartum Management in HIV-Positive Haitian Women: An Analysis of CD4 Decline, Mortality, and Follow-Up After Delivery (2012) (17)
Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160 (1992) (16)
Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection (1980) (16)
CULTURE VERSUS POLYMERASE CHAIN REACTION FOR THE ETIOLOGIC DIAGNOSIS OF COMMUNITY-ACQUIRED PNEUMONIA IN ANTIBIOTIC-PRETREATED PEDIATRIC PATIENTS (2009) (16)
Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5 (1992) (16)
Clinical manifestations of human immunodeficiency virus infection in Haitian children. (1997) (16)
Development and evaluation of an enzyme-linked immunosorbent assay for detection of bovine antibodies to epizootic hemorrhagic disease of deer viruses. (1992) (15)
THE ROLE OF RESPIRATORY TRACT PROTEASES IN THE INFECTIVITY OF INFLUENZA A VIRUS (1984) (15)
Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals (2020) (14)
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. (1977) (14)
Development and evaluation of an indirect enzyme immunoassay for detection of porcine antibodies to pseudorabies virus. (1986) (13)
Inflammatory pseudotumor presenting as fever of unknown origin. (1995) (13)
Reye's syndrome associated with adenovirus infections in infants. (1985) (13)
Laboratory and epidemiologic assessment of a recent influenza B outbreak (1988) (12)
Diffuse retinopathy following measles, mumps, and rubella vaccination. (1985) (12)
Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus. (1983) (12)
Thermostabilization of egg grown influenza viruses. (2002) (11)
Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments (2019) (11)
Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children (1989) (11)
The epidemiology of AIDS in Haiti refutes the claims of Gilbert et al. (2008) (11)
Enzyme immunoassay for diagnosis of bovine brucellosis. (1987) (11)
Diagnostic tests for poliovirus infection: a comparison of neutralization and immunofluorescence for the identification and typing of stool isolates. (1995) (10)
Genetic studies of respiratory syneytial virus temperature-sensitive mutants (2005) (10)
Detection of antibody in Aleutian disease of mink: comparison of enzyme-linked immunosorbent assay and counterimmunoelectrophoresis. (1982) (10)
Cytomegalovirus pneumonia in two infants recently adopted from China. (1999) (10)
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden (2019) (10)
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania (2020) (10)
Progress in the prevention and treatment of RSV infection. (2014) (9)
In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children. (1986) (9)
The use of inactivated influenza vaccine in children. (2006) (9)
Severe combined immunodeficiency associated with absent T4+ helper cells. (1984) (9)
Complex etiology of pneumonia in infants perinatally infected with human immunodeficiency virus 1. (1991) (9)
Electron microscopic studies of respiratory syneytial temperature-sensitive mutants (2005) (9)
Optimal Bandaging of Smallpox Vaccination Sites to Decrease the Potential for Secondary Vaccinia Transmission Without Impairing Lesion Healing (2006) (9)
Effect of meniscus formation and duplicate sample placement configurations on the variability of measurement by three microtiter plate photometers (1985) (9)
Effective delivery of IgG-antibodies into infected cells via dendritic molecular transporter conjugate IgGMT. (2008) (8)
The demise and rebirth of polio--a modern phoenix? (2008) (8)
Initial evaluation of kinetics and efficacy of moxalactam (LY-127935) in neonatal systemic gram-negative bacterial disease (1980) (8)
Mucosal Immunity: The Forgotten Arm of the Immune System. (2019) (8)
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. (1993) (8)
Endotoxin content and clinical reactivity to influenza vaccines. (1977) (7)
Minimizing the risks associated with the prevention of poliomyelitis. (1995) (7)
Live attenuated influenza vaccines. (1987) (7)
Application of Indirect ELISA for Detection of Bovine Antibodies against Vesicular Stomatitis Viruses (1993) (7)
How do influenza vaccines work? (2004) (7)
Evaluation of a Live, Attenuated Respiratory Syncytial Virus (RSV)Vaccine Candidate, cpts 248/404, in Infancy • 931 (1998) (7)
Cold-adapted influenza vaccines. (2002) (7)
Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants (2018) (7)
Circulating Vaccine Derived Poliovirus and the polio eradication endgame (2012) (7)
Application of Enzyme Immunoassay in Veterinary Medicine: Serodiagnosis of Bovine Brucellosis (1988) (6)
Maximising the impact of inactivated polio vaccines. (2017) (6)
Specificity of the indirect enzyme-linked immunosorbent assay for detection of pseudorabies virus antibodies in pigs exposed to bovine herpesvirus-1. (1987) (6)
Evaluation of a virus vaccine in live, attenuated respiratory syncytial (1976) (6)
Interactions of viruses with respiratory epithelial cells (1996) (6)
Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. (1991) (5)
A retrospective review of facility-level obstetric complications and stillbirths in southern Haiti, 2013 – 2016 (2019) (5)
Behavior of Vaccine Revertants of Temperature-Sensitive Mutants of Influenza Virus in Ferret Tracheal Organ Culture (1979) (5)
Indication and duration of antimicrobial agents for acute otitis media. (1984) (5)
Evaluation of an enzyme immunoassay for detection of antibodies to pseudorabies virus in porcine field sera. (1987) (5)
Live attenuated influenza vaccines in young seronegative children. (1977) (5)
Complement activation by respiratory syncytial virus-infected cells (2005) (4)
The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry. (1997) (4)
Seasonal Maintenance of Influenza Vaccine-Induced Antibody Response in Kidney Transplant Recipients (2012) (4)
Hearing, speech, and language sequelae of otitis media with effusion. (1991) (4)
Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial. (1977) (3)
22 – The Rationale for a Mucosal Approach to the Prevention of Respiratory Syncytial Virus-Associated Pulmonary Disease (1996) (3)
Effects of schistosomes on host anti-viral immune response and the acquisition, virulence, and prevention of viral infections: A systematic review (2021) (3)
Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium (2020) (3)
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials (2020) (3)
Does oseltamivir work against influenza B? (2007) (2)
Herpes encephalitis after infectious mononucleosis. (1981) (2)
Diagnosis of Tuberculosis Using Gastric Aspirates in Pediatric Patients in Haiti. (2020) (2)
LIVE PARAINFLUENZA TYPE 3 VACCINE IN CHILDREN (1977) (2)
Simultaneous screening of bovine sera for antibodies to bluetongue and epizootic hemorrhagic disease of deer viruses by enzyme-linked immunosorbent assay. (1992) (2)
1179 RHESUS ROTAVIRUS VACCINE IN CHILDREN (1985) (2)
Analysis of influenza specific CTL responses in children using fibroblasts as stimulator and target cells (2001) (1)
Experimental Respiratory Syncytial Virus Infection of Adults (1971) (1)
Influenza-associated acute necrotizing encephalopathy in a 2-year-old American child (2004) (1)
AMANTADINE FOR THE PROPHYLAXIS OF INFLUENZA IN PATIENTS WITH CYSTIC FIBROSIS (1974) (1)
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4D30 -4995 in Healthy Adult Volunteers (2009) (1)
Transplantation Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort Study (2009) (1)
825 CHARACTERISTICS OF INFLUENZA B INFECTION IN INFANTS COMPARED TO CHILDREN AND YOUNG ADULTS (1978) (1)
Response and Hemagglutinin Stalk-Reactive Antibody Production in Different Age Cohorts following 2009 H 1 N 1 Influenza Virus Vaccination (2018) (1)
Circulating vaccine-derived polioviruses: current state of (2004) (1)
Plotkin Lecture in Vaccinology (2019) (1)
A Novel Method to Determine Immunity to Vibrio Cholerae In A Previously Immunologically-Naïve Population (2011) (1)
Acute otitis media: The contributions of viruses, bacteria, genetics, and environment* (1995) (1)
Rubella Virus Plague Neutralization Test…Description of Assay and Comparison with Alternative Rubella Antibody Determination after Vaccination… (1981) (1)
In vitro modeling of the interaction between human epithelial cells and lymphocytes upon influenza infection (2016) (1)
Comparative efficacy of cold-adapted and inactivated influenza vaccines (1993) (0)
Bronchiolitis (1986) (0)
38 THE EPIDEMIOLOGY OF ROTAVIRUS INFECTION IN INFANTS AND THE PROTECTION AGAINST SYMPTOMATIC ILLNESS AFFORDED BY PRIMARY INFECTION AND VACCINATION (1996) (0)
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 D 30 -4995 in Healthy Adult Volunteers (2009) (0)
Behavior ofVaccine Revertants ofTemperature-Sensitive Mutants ofInfluenza Virus inFerret Tracheal OrganCulture (1979) (0)
Childhood vaccines and non-specific effects on mortality in the vaccinated population in Zaire (2003) (0)
SIMULTANEOUS ADMINISTRATION OF TWO LIVE INFLUENZA VACCINES (1984) (0)
34 – The Mycoses (2012) (0)
Vaccine-induced mucosal immunity from IPV-BOPV and IPV-only immunization schedules: analysis of an open-label, randomized controlled trial in chilean infants (2017) (0)
In Response (2016) (0)
LONG-TERM COINFECTION WITH PLASMODIUM FALCIPARUM AND P. MALARIAE PRESENTING AS SPLENOMEGALY DURING A WELL-CHILD PHYSICAL EXAMINATION (1998) (0)
1408. Enterovirus D68 RNA Visualized in the Anterior Horn of the Spinal Cord of a Pediatric Patient with Flaccid Paralysis (2020) (0)
Contributors (2006) (0)
Special Theme – Polio Eradication : End-Stage Challenges Circulating vaccine-derived polioviruses (2018) (0)
INFLUENZA B/ANN ARBOR: CLINICAL, LABORATORY, AND EPIDEMIOLOGIC DETECTION (1987) (0)
Potential of a Simplified p24 Assay for Early Diagnosis of Infant Human Immunodeficiency Virus Type 1 Infection in Haiti (2007) (0)
SÉVÈRE AND OTHERS EFFECTIVENESS OF ORAL CHOLERA VACCINE IN HAITI Effectiveness of Oral Cholera Vaccine in Haiti : 37-Month Follow-Up (2016) (0)
Antiretroviral therapy for HIV-1-infected children in Haiti. Commentary (2007) (0)
1091 AGE RELATED RESPONSE TO HEMOPHILUS INFLUENZAE TYPE B VACCINES (1981) (0)
Age-related response to two influenzae type b vaccines Haemophilus (1982) (0)
Authors' Addendum (1991) (0)
Laboratory Diagnosis of Viral Infections, E. Lennettee (Ed.). Marcel Dekker, New York (1985) (1985) (0)
Co-infection of primary human adenoid epithelial cells with Influenza A and Streptococcus pneumoniae (2004) (0)
Influenza- and Respiratory Syncytial Virus-Related Morbidity in Chronic Lung Disease (2016) (0)
Chapter 35 – The Mycoses (2006) (0)
Simultaneous Detection and High-Throughput Identiﬁcation of a Panel of RNA Viruses Causing Respiratory Tract Infections (cid:1) (2007) (0)
Vaccine-associated poliomyelitis sex-linked agammaglobulinemia in a child with (1977) (0)
Maternal alum-adjuvanted recombinant HIV Env vaccine does not enhance autologous virus neutralization in HIV-infected pregnant women (2019) (0)
Cervical-vaginal lavages from HIV positive- and HIV negative-women contain immune factors that have intrinsic anti-HIV activity (2009) (0)
SAFETY AND IMMUNOGENICITY OF LIVE ATTENUATED HUMAN-BOVINE (UK) REASSORTANT ROTAVIRUS VACCINE WITH VP7-SPECIFICITY FOR SEROTYPE 4 (G4) IN CHILDREN AND YOUNG INFANTS (1999) (0)
1092 INFLUENCE OF ACUTE AND SEROUS OTITIS IN INFANCY ON HEARING TESTING AT 2 YEARS OF AGE (1981) (0)
Mucosal Immune Response to Trivalent Live Attenuated Intranasal Influenza Vaccine in Children ♦ 815 (1998) (0)
The dangers of castor oil tea in neonates in rural Haiti: A case report (2023) (0)
1067 CLINICAL STUDIES IN INFANTS OF TWO PNEUMOCOCCAL VACCINES (1981) (0)
INTERACTION OF INFLUENZA WITH HUMAN NASOPHARYNGEAL MUCOSA (1984) (0)
Application of an ELISA for detection of antibodies to epizootic hemorrhagic disease viruses in bovine sera (1992) (0)
Absence of pharyngeal shedding of vaccinia following smallpox vaccination. (2007) (0)
A Clinical Isolate Strain of Respiratory Syncytial Virus (RSV) Causes Airway Obstruction and Histopathology in Mice Similar to Severe RSV Disease in Infants (2008) (0)
Book Review Vaccines Second edition. Edited by Stanley A. Plotkin and Edward A. Mortimer, Jr. 996 pp., illustrated. Philadelphia, W.B. Saunders, 1994. $159. 0-7216-6584-5 (1995) (0)
Introduction: Viral pathogenesis (1996) (0)
Lack of relationship of community patterns of respiratory viral activity to systemic Haemophilus influenzae disease in children (1982) (0)
Evidence-Based Neonatal Infections (2014) (0)
#16: Enterovirus D68 Visualized in the Anterior Horn of the Spinal Cord of a Pediatric Patient with Flaccid Paralysis (2021) (0)
FACTORS CONFERRING PROTECTION AGAINST ROTAVIRUS INFECTION IN CHILDREN (1999) (0)
New Vaccines of Interest to Women (2004) (0)
following Smallpox Immunization Perforin in Effector and Memory T Cells Differential Regulation of Granzyme and (2017) (0)
Initial evaluation of LY-127935 in treatment of systemic gram-negative bacterial disease in neonates (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Farnum Wright?

Peter Farnum Wright is affiliated with the following schools:

Peter Farnum Wright's Academic­Influence.com Rankings

Peter Farnum Wright's Degrees

Similar Degrees You Can Earn

Why Is Peter Farnum Wright Influential?

Peter Farnum Wright's Published Works

Published Works

What Schools Are Affiliated With Peter Farnum Wright?

Peter Farnum Wright's AcademicInfluence.com Rankings